STEMI - ST Elevation Myocardial Infarction Clinical Trial
Official title:
In-hospital Versus After-discharge Complete Revascularization in STEMI Patients With Multivessel Disease.
Patients with STEMI and multivessel disease in whom the culprit lesion has been successfully revascularized during prmimary PCI, will be randomized to in-hospital or after-discharge complete revascularization. The purpose of this study is to evaluate the impact of these two different strategies in terms of hospital stay.
STEMI patients with mutivessel disease are, after successful primary angioplasty, randomized 1:1 ratio to either in-hospital complete revascularization or after-discharge complete revascularization strategy. Eligible non-culprit coronary arteries must be >2.0 mm in diameter and at the discretion of the operator suitable for PCI. Only arteries with angiographically stenoses ≥70% or between ≥50% and <70 in proximal segments can be randomized. Patients in the in-hospital revascularization group will undergo to non-culprit percutaneous coronary intervention (PCI) at least 24 hours after ST-segment elevation myocardial infarction. On the other hand, patients in the after-discharge group will undergo to non-culprit PCI within 4-6 weeks after STEMI. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
| Terminated |
NCT04542889 -
Coronary Microcirculation Assessment After Primary Angioplasty in Myocardial Infarction
|
N/A | |
| Recruiting |
NCT04951856 -
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
|
Phase 4 | |
| Terminated |
NCT04459299 -
CorPath GRX STEMI Study
|
||
| Recruiting |
NCT05557019 -
Semi Occlusion of the Coronary Sinus as an Adjunct to PCI in STEMI Patients, FIH Clinical Study
|
N/A | |
| Completed |
NCT03527940 -
Prognostic Markers of Patients With STEMI
|
||
| Not yet recruiting |
NCT03264859 -
NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
|
N/A | |
| Not yet recruiting |
NCT03182855 -
Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
|
Phase 4 | |
| Not yet recruiting |
NCT03266289 -
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
|
N/A | |
| Withdrawn |
NCT04566289 -
Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
|
||
| Completed |
NCT04289012 -
HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study
|
N/A | |
| Not yet recruiting |
NCT04185077 -
Bivalirudin in Late PCI for Oatients With STEMI
|
Phase 4 | |
| Completed |
NCT03609346 -
Asian Registry of the BioFreedom Stent for STEMI Patients
|
||
| Recruiting |
NCT05107076 -
Effect of PPCI on Diastolic Function & Levels of Galactin-3 in Patients With STEMI
|
||
| Recruiting |
NCT02998853 -
Non Culprit Functional Evaluation With 3D Angio QFR in STEMI PCI Procedure
|
N/A | |
| Completed |
NCT03677180 -
National Cardiogenic Shock Initiative
|
||
| Completed |
NCT03507777 -
ILUMIEN IV: OPTIMAL PCI
|
N/A | |
| Recruiting |
NCT03863327 -
EKG Criteria and Identification of Acute Coronary Occlusion
|
||
| Completed |
NCT03070496 -
Multicenter Cohort of STEMI Patients
|
N/A | |
| Active, not recruiting |
NCT03874338 -
CLEAR SYNERGY Neutrophil Substudy
|